Dongkoo Bio & Pharma Co., Ltd.

République de Corée

Retour au propriétaire

1-13 de 13 pour Dongkoo Bio & Pharma Co., Ltd. Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 11
        Marque 2
Juridiction
        International 12
        États-Unis 1
Date
2023 1
2022 1
Avant 2020 11
Classe IPC
A61M 1/02 - Appareils pour transfusion sanguine d'un corps à un autre 4
C12M 1/24 - Appareillage pour l'enzymologie ou la microbiologie en forme de tube ou de bouteille 3
A61J 1/05 - Récipients spécialement adaptés à des fins médicales ou pharmaceutiques pour recueillir, stocker ou administrer du sang, du plasma ou des liquides à usage médical 2
A61M 1/34 - Filtration du sang à travers une membrane pour en éliminer une matière, c.-à-d. hémofiltration, diafiltration 2
A61M 5/14 - Dispositifs de perfusion, p. ex. perfusion par gravitéPerfusion sanguineAccessoires à cet effet 2
Voir plus

1.

CELL BLOOM

      
Numéro de série 97744860
Statut Enregistrée
Date de dépôt 2023-01-06
Date d'enregistrement 2024-01-23
Propriétaire DONGKOO BIO & PHARMA CO., LTD. (République de Corée)
Classes de Nice  ? 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.

Produits et services

Cosmetics; Cosmetic creams for skin care; Cosmetic preparations for skin care; Facial cleansers; Skin moisturizer masks; Sun block

2.

DR.DK

      
Numéro d'application 1704544
Statut Enregistrée
Date de dépôt 2022-11-15
Date d'enregistrement 2022-11-15
Propriétaire DONGKOO BIO & PHARMA CO., LTD. (République de Corée)
Classes de Nice  ? 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.

Produits et services

Massage oils and lotions; make-up; cosmetic preparations for the hair and scalp; cosmetic preparations for baths; body and beauty care cosmetics; shampoos; sun screen preparations; toiletry preparations; cosmetic preparations for skin care; cosmetics for spa; essential oils; skin cleansing foams; cosmetic preparations for skin renewal; hand lotions; perfume; hair conditioner; oils for hair conditioning; hair care preparations; mask pack for cosmetic purposes; cosmetic preparations.

3.

AGENTS FOR PREVENTING OR TREATING URINARY DISEASE AND PREPARING THE SAME

      
Numéro d'application KR2017013385
Numéro de publication 2019/013403
Statut Délivré - en vigueur
Date de dépôt 2017-11-23
Date de publication 2019-01-17
Propriétaire DONGKOO BIO & PHARMA CO., LTD. (République de Corée)
Inventeur(s)
  • Kim, Yun-Sik
  • Son, Ji-Won
  • Kim, Yun-Young
  • Choo, Eui-Jin
  • Youn, Ju-Hee
  • Kim, Hye-Jin
  • Lee, Ji-Eun

Abrégé

The present disclosure provides an agent for preventing or treating urinary disease, which contains tamsulosin or a pharmaceutically acceptable salt thereof, a PDE-5 inhibitor and a muscarinic receptor antagonist, and a method for preparing the same. The pharmaceutical agent according to the present disclosure, which contains tamsulosin, a PDE-5 inhibitor and a muscarinic receptor antagonist, is capable of treating benign prostatic hypertrophy, erectile dysfunction and bladder disease at the same time. In addition, the pharmaceutical agent according to the present disclosure provides a sustained-release effect and reduces treatment period and side effects.

Classes IPC  ?

  • A61K 9/24 - Pilules, pastilles ou comprimés du type à libération prolongée ou discontinue en doses unitaires constituées de couches ou feuilletées
  • A61K 31/18 - Sulfamides
  • A61K 31/4985 - Pyrazines ou pipérazines condensées en ortho ou en péri avec des systèmes hétérocycliques
  • A61K 31/439 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec un azote comme seul hétéro-atome d'un cycle le cycle formant une partie d'un système cyclique ponté, p. ex. quinuclidine
  • A61K 9/20 - Pilules, pastilles ou comprimés
  • A61K 9/50 - Microcapsules

4.

PHARMACEUTICAL COMPOSITION FOR ENHANCING BIOAVAILABILITY OF DRUG FOR TREATMENT OF ACNE

      
Numéro d'application KR2017012181
Numéro de publication 2018/080284
Statut Délivré - en vigueur
Date de dépôt 2017-10-31
Date de publication 2018-05-03
Propriétaire DONGKOO BIO & PHARMA CO., LTD. (République de Corée)
Inventeur(s)
  • Kim, Yun-Sik
  • Kim, Han-Gyu
  • Choo, Eui-Jin
  • Moon, Se-Hui

Abrégé

The present invention relates to a pharmaceutical composition comprising retinoid and benzoyl peroxide and, more specifically, to a pharmaceutical composition for treating acne with enhanced bioavailability in the form of a cream gel comprising adapalene and dispersed benzoyl peroxide. The pharmaceutical composition according to the present invention is excellent in skin affinity as the composition contains pseudoceramides which are very similar to natural ceramides, and has an effect of improving skin usability such as the stability of the product, skin moisturizing power and feeling of use, skin barrier formation and the like as the composition contains a multilamellar emulsion which is very similar to a lamellar structure which is a lipid structure between dermal keratinocytes. In addition, the pharmaceutical composition according to the present invention is non-toxic and has an excellent therapeutic effect on acne lesions without inducing skin irritation.

Classes IPC  ?

  • A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
  • A61K 31/21 - Esters, p. ex. nitroglycérine, sélénocyanates

5.

MEDICAL INJECTION DEVICE

      
Numéro d'application KR2017003039
Numéro de publication 2017/204448
Statut Délivré - en vigueur
Date de dépôt 2017-03-22
Date de publication 2017-11-30
Propriétaire DONGKOO BIO & PHARMA CO., LTD. (République de Corée)
Inventeur(s) Kim, Jun-Woo

Abrégé

The present invention relates to a medical injection device for: preventing, in advance, a fatal medical accident, which can be caused by uneven concentration of the target substance, by inducing a target material, which is contained in an injection solution, to be injected in a uniform concentration in a sufficiently agitated state since vibration is provided such that the injection solution is agitated by the shaking of a container having the injection solution contained therein and an agitation means provided within the container; particularly, allowing the container to be connected with a filter and/or an expansion tube by means of an injection solution level control tube, thereby allowing the level of the injection solution filled therein and the injection rate of the injection solution to be more freely controlled; and, particularly, having an effect of allowing a target material such as stem cells to be injected while being stably filtered without sustaining damage caused by an injection filter medium and the like since the injection solution is induced to be injected in a state in which the injection solution is filled inside the filter to a predetermined level or higher so as to pass through a sedimentation filtration process inside the filter.

Classes IPC  ?

  • A61M 5/14 - Dispositifs de perfusion, p. ex. perfusion par gravitéPerfusion sanguineAccessoires à cet effet
  • A61M 5/168 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte
  • A61M 5/165 - Accessoires de filtrage, p. ex. filtres pour le sang, pour les liquides de perfusion
  • A61J 1/20 - Dispositions pour le transfert des liquides, p. ex. du flacon à la seringue
  • A61J 1/14 - Récipients spécialement adaptés à des fins médicales ou pharmaceutiques DétailsAccessoires à cet effet

6.

MEDICAL INJECTION DEVICE

      
Numéro d'application KR2017001630
Numéro de publication 2017/142296
Statut Délivré - en vigueur
Date de dépôt 2017-02-15
Date de publication 2017-08-24
Propriétaire DONGKOO BIO & PHARMA CO., LTD. (République de Corée)
Inventeur(s) Kim, Jun-Woo

Abrégé

The present invention provides an injection device wherein cells in an injection solution are administered at a low concentration by generating vibration in the injection device and stirring the injection solution by a stirring device to prepare a diluted solution of the cells, and the generated vibration is prevented from being transmitted up to a syringe device, so as not to hurt a person to which the injection solution is administered. The injection device comprises: a container in which an injection solution is stored such that the injection solution can be administered at a constant rate or at a controlled rate; an inflow port which is formed in the container and through which an injection solution can be supplied into the container; a stirring means installed in the container so as to stir an injection solution in the container when vibration is generated in the container; an injection unit formed in a lower portion of the container so as to inject an injection solution in the container through a guide tube; and a vibration damping device installed in the injection unit so as to damp vibration generated in the container, wherein the lower portion of the container includes an inclined section for guiding the injection solution toward an outlet part.

Classes IPC  ?

  • A61M 5/14 - Dispositifs de perfusion, p. ex. perfusion par gravitéPerfusion sanguineAccessoires à cet effet
  • A61M 5/168 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte
  • A61M 39/22 - Soupapes ou agencement de soupapes
  • B01F 11/00 - Mélangeurs avec mécanismes à secousses, oscillants ou vibrants
  • A61M 5/165 - Accessoires de filtrage, p. ex. filtres pour le sang, pour les liquides de perfusion

7.

PHARMACEUTICAL COMPOSITION HAVING IMPROVED STABILITY AND SKIN PENETRATION

      
Numéro d'application KR2016004688
Numéro de publication 2016/182258
Statut Délivré - en vigueur
Date de dépôt 2016-05-04
Date de publication 2016-11-17
Propriétaire DONGKOO BIO&PHARMA CO.,LTD (République de Corée)
Inventeur(s)
  • Kim, Yun Sik
  • Choo, Eui Jin
  • Hwang, Kyu Hyeon
  • Lim, Yoo Jin
  • Lee, Hwan Hyuk
  • Choi, Sung Hoon

Abrégé

The present invention relates to a pharmaceutical composition for local skin, which, while containing at least one vitamin D or vitamin D homologue and at least one corticosteroid, has a reduction in stability deterioration due to a mutual reaction and an improvement in skin penetration. The stabilized composition containing at least one vitamin D or vitamin D homologue and at least one corticosteroid, of the present invention, solves problems of reducing contents and deteriorating pharmaceutical effects, caused by a mutual reaction occurring between the active ingredients, thereby obtaining not only effects of promoting appearance stability and content stability of a medical product but also an effect of reducing side effects caused by the generation of impurities. In addition, the use of at least one skin penetrating agent selected from C12-24 straight-chain alkanols and squalene leads to an improvement in skin penetration, thereby expecting a rapid therapeutic effect.

Classes IPC  ?

  • A61K 31/59 - Composés contenant le système cyclique du 9,10-séco-cyclopenta[a]hydrophénanthrène
  • A61K 31/573 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes substitués en position 17 bêta par une chaîne à deux atomes de carbone, p. ex. prégnane ou progestérone substitués en position 21, p. ex. cortisone, dexaméthasone, prednisone ou aldostérone
  • A61K 31/01 - Hydrocarbures
  • A61K 9/06 - OnguentsExcipients pour ceux-ci

8.

COMPONENT SEPARATOR

      
Numéro d'application KR2015004463
Numéro de publication 2015/174671
Statut Délivré - en vigueur
Date de dépôt 2015-05-04
Date de publication 2015-11-19
Propriétaire DONGKOO BIO PHARMA CO., LTD. (République de Corée)
Inventeur(s) Kim, Jun-Woo

Abrégé

The present invention relates to a component separator capable of guaranteeing the purity of a target component such as isolated blood or stem cells while simplifying a process compared with a conventional technique, and preventing air contamination during a component separation process, the component separator comprising: a hollow main body having a circulation pipe, through which a body fluid circulates, formed at one end part, and a main body female screw part disposed at the other end part; a plunger for varying the main body space of the main body while moving forward and backward inside the main body; and an operation member having a pressurization tube having a pressurization screw part capable of being screw-coupled to the main body female screw part, and a plunger coupling tube having a tube screw screw-coupled to a plunger screw part at the lower part of the plunger by coming into contact with or retracting from the inside of the pressurization tube.

Classes IPC  ?

  • A61M 1/02 - Appareils pour transfusion sanguine d'un corps à un autre
  • C12M 1/24 - Appareillage pour l'enzymologie ou la microbiologie en forme de tube ou de bouteille
  • A61M 1/34 - Filtration du sang à travers une membrane pour en éliminer une matière, c.-à-d. hémofiltration, diafiltration
  • A61J 1/05 - Récipients spécialement adaptés à des fins médicales ou pharmaceutiques pour recueillir, stocker ou administrer du sang, du plasma ou des liquides à usage médical

9.

FAT CRUSHER AND COMPONENT SEPARATOR ALLOWING FAT CRUSHING

      
Numéro d'application KR2014011885
Numéro de publication 2015/088194
Statut Délivré - en vigueur
Date de dépôt 2014-12-05
Date de publication 2015-06-18
Propriétaire DONGKOO BIO PHARMA CO., LTD. (République de Corée)
Inventeur(s) Kim, Jun-Woo

Abrégé

The present invention relates to a fat crusher and a component separator allowing fat crushing, wherein the fat crusher has a simple structure and crushes fat tissue by a physical method to convert the fat tissue into a state in which stem cells can be easily isolated. As a result, collagenase which has been used to isolate stem cells in the prior art may not be used or may be used less, thereby omitting or dramatically reducing a washing work of collagenase and significantly reducing costs and manpower necessary for isolation of stem cells through exclusion or reduction of high-priced collagenase, and thus medical services using stem cells can be popularized.

Classes IPC  ?

  • C12M 1/33 - Désintégrateurs
  • C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse

10.

COMPONENT SEPARATOR

      
Numéro d'application KR2014008032
Numéro de publication 2015/037845
Statut Délivré - en vigueur
Date de dépôt 2014-08-28
Date de publication 2015-03-19
Propriétaire DONGKOO BIO & PHARMA CO., LTD. (République de Corée)
Inventeur(s) Kim, Jun-Woo

Abrégé

The present invention relates to a component separator having a check valve tube which is opened only when external force is applied thereto, especially only during centrifugation, enabling communication between an upper chamber and a lower chamber, and comprising: the upper chamber having an upper space therein and having at least one upper port; the lower chamber connected with the upper chamber, having a lower space that is in communication with the upper space, and having at least one lower port; and the check valve tube opening and closing a neck portion formed in the upper chamber, and communicating with only the lower chamber when the neck portion is closed, wherein the check valve tube comprises: a tube main body penetrating through the upper chamber; a diaphragm expanded at the lower portion of the tube main body to close the neck portion; and a spring formed at the top of the upper chamber to apply elastic force to the tube main body.

Classes IPC  ?

  • C12M 1/10 - Appareillage pour l'enzymologie ou la microbiologie montés rotativement
  • C12M 1/24 - Appareillage pour l'enzymologie ou la microbiologie en forme de tube ou de bouteille

11.

COMPONENT SEPARATOR

      
Numéro d'application KR2014003578
Numéro de publication 2014/178570
Statut Délivré - en vigueur
Date de dépôt 2014-04-24
Date de publication 2014-11-06
Propriétaire DONGKOO BIO PHARMA CO., LTD. (République de Corée)
Inventeur(s) Kim, Jun-Woo

Abrégé

The present invention relates to a component separator which: can simplify a process when compared to the prior art; can ensure the purity of a component such as a separated stem cell or blood and the like; can prevent air pollution during a component separation step; and has a simple structure, the component separator comprising: an upper chamber having an upper space therein and one or more upper ports; a lower chamber which is connected to the upper chamber, and which has a lower space communicated with the upper space and one or more lower ports; and an isolation means provided in the upper chamber or the lower chamber so as to close a gap between the upper chamber and the lower chamber, and isolating the upper space from the lower space.

Classes IPC  ?

  • A61M 1/02 - Appareils pour transfusion sanguine d'un corps à un autre
  • A61J 1/05 - Récipients spécialement adaptés à des fins médicales ou pharmaceutiques pour recueillir, stocker ou administrer du sang, du plasma ou des liquides à usage médical

12.

COMPONENT SEPARATOR

      
Numéro d'application KR2013010954
Numéro de publication 2014/168311
Statut Délivré - en vigueur
Date de dépôt 2013-11-29
Date de publication 2014-10-16
Propriétaire DONGKOO BIO & PHARMA CO., LTD. (République de Corée)
Inventeur(s) Kim, Jun-Woo

Abrégé

The present invention relates to a component separator having a simple structure, which can ensure the purity of components such as separated stem cells or blood and the like while simplifying a process compared with a conventional technique, can prevent air pollution during a component separation process, and comprises: an upper chamber having an upper space therein; a lower chamber connected with the upper chamber and having a lower space communicating with the upper space; and an isolation means provided to the upper chamber to isolate the upper space and the lower space by sealing a gap therebetween, and communicating with the lower chamber in a state wherein the upper space and the lower space are isolated.

Classes IPC  ?

  • C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
  • C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse
  • C12M 1/10 - Appareillage pour l'enzymologie ou la microbiologie montés rotativement
  • A61M 1/02 - Appareils pour transfusion sanguine d'un corps à un autre

13.

COMPONENT SEPARATOR

      
Numéro d'application KR2013000390
Numéro de publication 2013/133529
Statut Délivré - en vigueur
Date de dépôt 2013-01-18
Date de publication 2013-09-12
Propriétaire DONGKOO BIO & PHARMA CO., LTD. (République de Corée)
Inventeur(s) Kim, Jun-Woo

Abrégé

The present invention relates to a component separator which can ensure the purity of components such as separated blood, stem cells, and the like while simplifying a process, compared with a known technique, and can prevent air pollution during the separation of components. The component separator comprises: a hollow main body in which a flow pipe for body fluids is formed at one end and a stopper is placed at the other end; and a plunger for varying the space within the flow pipe while moving forward and backward inside the main body, wherein a collection portion is formed at the upper portion of the plunger, and the backward movement of the plunger is restricted by the stopper.

Classes IPC  ?

  • A61M 1/02 - Appareils pour transfusion sanguine d'un corps à un autre
  • A61M 1/34 - Filtration du sang à travers une membrane pour en éliminer une matière, c.-à-d. hémofiltration, diafiltration
  • C12M 1/24 - Appareillage pour l'enzymologie ou la microbiologie en forme de tube ou de bouteille